Watch this on-demand webinar held on October 06, 2022, to learn more about the challenges for developing new generation vectors and effective process improvements to increase the utility of CHO DG44 as a cell line development platform.
In this webinar, Dr. Sufia Karim, Director, Cell Line Development, Aragen Life Sciences will highlight on:
Challenges faced while using the dihydrofolate reductase (DHFR)-deficient CHO DG44 platform
New generation vectors and process design improvements to improve CHO DG44 as a cell line development platform
Dr. Sufia Karim
Director Cell Line Development, Aragen Life Sciences
Challenges faced while using the dihydrofolate reductase (DHFR)-deficient CHO DG44 platform
New generation vectors and process design improvements to improve CHO DG44 as a cell line development platform
Dr. Sufia Karim
Director Cell Line Development, Aragen Life Sciences
